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Abstract The heart’s rhythm is initiated and regulated by
a group of specialized cells in the sinoatrial node (SAN),
the primary pacemaker of the heart. Abnormalities in the
development of the SAN can result in irregular heart rates
(arrhythmias). Although several of the critical genes
important for SAN formation have been identified, our
understanding of the transcriptional network controlling
SAN development remains at a relatively early stage. The
homeodomain transcription factor Shox2 is involved in the
specification and patterning of the SAN. While the Shox2
knockout in mice results in embryonic lethality due to
severe cardiac defects including improper SAN develop-
ment, Shox2 knockdown in zebrafish causes a reduced
heart rate (bradycardia). In order to gain deeper insight into
molecular pathways involving Shox2, we compared gene
expression levels in right atria of wildtype and Shox2-/-
hearts using microarray experiments and identified the LIM
homeodomain transcription factor Islet1 (Isl1) as one of its
putative target genes. The downregulation of Isl1 expres-
sion in Shox2-/- hearts was confirmed and the affected
region narrowed down to the SAN by whole-mount in situ
hybridization. Using luciferase reporter assays and EMSA
studies, we identified two specific SHOX2 binding sites
within intron 2 of the ISL1 locus. We also provide func-
tional evidence for Isl1 as a transcriptional target of Shox2
by rescuing the Shox2-mediated bradycardia phenotype
with Isl1 using zebrafish as a model system. Our findings
demonstrate a novel epistatic relationship between Shox2
and Isl1 in the heart with important developmental conse-
quences for SAN formation and heart beat.
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Introduction
During embryogenesis most cells have to become spe-
cialized into one of many various cell types that build a
whole organism. These patterning and differentiation pro-
cesses are ensured by the temporal and spatial activation of
different transcription factors [50]. Homeobox genes, for
example, regulate numerous processes during embryogen-
esis including heart development. Complex transcriptional
regulation networks are important in many aspects of heart
cell lineage development and morphogenesis [46].
The cardiac conduction system consists of electrically
coupled cardiomyocytes that are responsible for impulse
propagation and essential for the rhythmic and coordinated
contraction of the heart. A specialized group of cells in the
sinoatrial node (SAN) located at the junction of the
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superior caval vein and right atrium generates the electric
impulse to activate the atrial myocardium (also termed
primary pacemaker). Together with specialized cells in the
atrioventricular node (termed secondary pacemaker) and
conduction fibers in the interventricular septum, they form
the cardiac conduction system [7, 19]. Abnormalities in the
cardiac conduction pathway are responsible for various
forms of arrhythmias [41, 44, 58]. Sinus node dysfunction,
for example, is associated with sinus bradycardia, atrial
tachyarrhythmias, sinus pause or arrest and sinoatrial exit
block [10]. Although the morphology, cellular components
and electrophysiological properties of the SAN are rather
well described [34, 38], knowledge of pathways and tran-
scriptional regulation of the SAN formation are poorly
understood. Unraveling the pathways that control pace-
maker development and function is of crucial relevance to
our understanding of pathologies associated with cardiac
conduction.
So far, several transcription factors of the homeobox-
and T-box gene families have been shown to be involved in
cardiac conduction system specification, patterning, matu-
ration, and function [17, 37]. Among these genes is the
paired-related homeodomain transcription factor Shox2,
which is known to play a crucial role in early cardiac
formation, particularly in SAN development and specifi-
cation [2, 11, 12, 30, 42]. Shox2 expression can first be
detected in the posterior region of the primitive heart tube
at murine embryonic stage E8.5 and as development pro-
gresses, Shox2 is specifically expressed in the sinus veno-
sus myocardium comprising the SAN and the venous
valves [2, 12]. These Shox2 expressing domains develop
from myocardium that is added to the venous pole of the
developing heart and contributes to the second heart field
lineage [5, 52]. Newly recruited myocardium that is added
to the arterial pole is divided into the anterior or secondary
heart field, while the myocardium added to the venous pole
is referred to as the posterior heart field [15]. Loss of
function studies revealed an essential role for Shox2 in the
normal anlage of the posterior heart field myocardium [2,
12]. Shox2-/- mice die between E11.5 and E17.5 due to
heart failure and vascular defects. In particular, the sinus
venosus myocardium including the SAN and venous valves
show hypoplasia. Moreover, Shox2 has a crucial role in
pacemaker function indicated by severe bradycardia with
intermittent sinus exit block after morpholino-mediated
knockdown in zebrafish embryos and markedly reduced
heart beat rates of isolated Shox2-/- hearts [2, 12]. To
investigate the molecular processes underlying Shox2
function, different marker gene expression analyses have
been performed. The aberrant expression of Cx40, Cx43,
Nppa, and Nkx2.5 within the SAN of Shox2 mutant hearts
as well as the decreased expression of the SAN-specific
marker genes Tbx3 and Hcn4 has indicated an abnormal
differentiation of pacemaker cells [2, 12]. It has also been
shown that Shox2 prevents the SAN from atrialization by
repressing Nkx2.5 expression [11, 12]. Recently, a further
link between Tbx5, Shox2 and Bmp4 could be established
in the developing heart, demonstrating that Tbx5 signaling
in the cardiac pacemaker region controls the expression of
Shox2, which in turn regulates Bmp4 in a direct manner
[42]. It has also been reported that Pitx2c represents an
important susceptibility gene for atrial arrhythmias by
suppressing left-sided sinus node formation via direct
repression of Shox2 [25, 53]. Taken together, these findings
illustrate the importance of Shox2 function in SAN devel-
opment and highlight the need for further elucidation of the
molecular networks involved.
The aim of our current study was to identify Shox2
target genes during heart development. We used expression
analysis to compare the transcriptomes in right atria of
wildtype and Shox2-/- mouse hearts, and Islet1 (Isl1) was
identified as a direct transcriptional target. We have
examined putative regulatory elements in the human ISL1
gene and show a pivotal role for sequences within intron 2
in activating transcription. Furthermore, a functional link
between Shox2 and Isl1 in vivo was demonstrated using
zebrafish as a model by rescuing the Shox2-mediated bra-
dycardia via ectopic expression of Isl1.
Methods
Animals and tissue samples
Shox2-/- mice were generated and genotyped as previ-
ously described [2]. For maximal reproduction, we crossed
our mice into the CD-1 outbred strain. To improve speci-
ficity of the microarray analysis, we dissected the right
atria of E11.5 hearts that comprise the Shox2 expressing
sinus venosus myocardium and venous valves. For total
RNA isolation by TRIzol (Invitrogen), samples from
embryonic right atria (E11.5) of the same genotype
(wildtype and Shox2-/-) were pooled. For whole-mount
in situ hybridization, complete hearts were dissected from
E11.5 and E12.5 embryos and fixed overnight in 4 %
paraformaldehyde at 4 C.
Microarray analysis
Gene expression profiling was performed using the Gene-
Chip Mouse Gene 1.0 ST array from Affymetrix (Santa
Clara, CA) according to the manufacturer’s protocol. For
each genotype (wildtype and Shox2-/-), RNA from 6 right
atria from embryos of 2 independent pregnancies was
pooled. Purity and quality of isolated RNA were assessed
by the Agilent 2100 Bioanalyzer (Agilent Technologies,
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Santa Clara, CA) and showed a RIN[9. 200 ng RNA were
used for production of end-labeled biotinylated ssDNA and
subsequently hybridized to the arrays. Statistical compari-
sons of chip data based on ANOVA were performed using
the software package JMP Genomics, version 4.0 from SAS
(SAS Institute, Cary, NC, USA). Briefly, values of perfect-
matches were log transformed, quantile normalized and fit-
ted with log-linear models, with probe ID and genotype
considered to be constant. Custom CDF version 14 with
Entrenz gene-based gene definitions (http://brainarray.
mbni.med.umich.edu/Brainarray/Database/CustomCDF/
genomic_curated_CDF.asp) different from the original
Affymetrix probe set definitions was used to annotate the
arrays. The microarray data were deposited in the NCBI
GEO database with accession number GSE39924.
Quantitative RT-PCR
cDNA was synthesized using the SuperScriptTM First-
Strand Synthesis System for RT-PCR (Invitrogen). Quan-
titative RT-PCR (qRT-PCR) was performed on a 7500 Fast
Real-Time PCR System (Applied Biosystems) using SYBR
Green ROX dye (Thermo Scientific). Primer sets used are
presented in Supplemental Material (Table S1).
Generation of plasmid constructs
Cloning of the murine Isl1 in situ probe, the zebrafish
shox2 and isl1 expression constructs, the human SHOX2a
expression construct and generation of the ISL1 luciferase
reporter constructs are described online in the Supple-
mental Material.
In situ hybridization
Shox2-/- mice have been described previously [2]. Whole-
mount in situ hybridization on embryonic mouse hearts
was performed as reported [16]. Specific digoxygenin- or
fluorescein-labeled RNA probes were as follows: Isl1 (see
Supplemental Material) and Hcn4 (kindly provided by B.
Bruneau, Gladstone Institute of Cardiovascular Disease,
USA).
Immunohistochemistry
E11.5 embryos were fixed in 4 % paraformaldehyde
at 4 C overnight, embedded in OCT and transversely
cryosectioned (10 lm). Tbx18 and Hcn4 stainings were
enhanced using the ABC (Avidin–Biotin-Complex) reagent
from Vector Laboratories (VECTASTAIN Elite Peroxidase
ABC-Kit) and the TSA (Tyramide Signal Amplification)
system (NEL741, Perkin Elmer) according to the manu-
facturers’ instructions. For double staining (Isl1/Tbx18 or
Isl1/Hcn4), the respective fluorescent secondary antibody
was added either during the biotinylated antibody incuba-
tion or in a second step afterwards. The following primary
antibodies were used: mouse monoclonal antibody against
Isl1 (1:100; 39.4D5, Developmental Studies Hybridoma
Bank), goat polyclonal antibody against Tbx18 (1:250;
C-20, Santa Cruz) and rabbit polyclonal antibody against
Hcn4 (1:500; APC-052, Alomone). Alexa Fluor 568 rabbit
anti-mouse (1:800; A-11061, Invitrogen), biotinylated
horse anti-goat (1:500; BA-9500, Vector Laboratories) and
biotinylated goat anti-rabbit (1:500; 550338, BD Pharmin-
gen) were used as secondary antibodies. Nuclei were
counterstained with Hoechst (Invitrogen). Imaging was
carried out on a Nikon 90i upright epi-fluorescence micro-
scope with a Nikon DS-Qi1 mc camera.
Cell culture, transfection and luciferase assay
HEK 293 cells were cultured at 37 C in DMEM medium
containing high glucose, supplemented with 10 % fetal calf
serum and antibiotics. For luciferase assay analysis, the
cells were cotransfected in triplicate with different con-
structs using polyethylenimine (Sigma-Aldrich). 24 h after
transfection, luciferase activity was determined and nor-
malized to Renilla luciferase activity with a dual luciferase
assay kit (Promega). Experiments were repeated at least
three times in triplicate with consistent results and repre-
sentative data are shown.
Electrophoretic mobility shift assay
Electrophoretic mobility shift assay (EMSA) was per-
formed using standard protocols. For the binding reaction,
32P-labeled, double stranded ISL1 oligonucleotides (Oligo1
(?2364/?2418), Oligo2 (?2404/?2458), Oligo3 (?2447/
?2502), Oligo4 (?2496/2561); Supplemental Material
Table S1), were used together with purified, bacterially
expressed recombinant GST-SHOX2 protein [3].
Zebrafish embryos and microinjections
Care and breeding of zebrafish, Danio rerio, were as
described previously [55]. For all plasmid and morpholino
injection procedures, the TE4/6 wildtype strain was used.
Morpholino-modified antisense oligonucleotides (MO;
Gene Tools) were directed against the translational start
site (shox2-MO [50-ACGCTGTAAGTTCTTCCATCACT
GC-30]) of zebrafish shox2, the splice donor site of exon 2
(isl1-MO [50-TTAATCTGCGTTACCTGATGTAGTC-30])
of zebrafish isl1 and the translational start site (isl1-MO2
[50-GATCCCCCATGTCTCCCATGTCAAG-30] of zebra-
fish isl1. A shox2-MO directed against the splice donor site
of intron 3 causing the identical bradycardia phenotype has
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been described previously [2]. shox2 and isl1 antisense
oligonucleotides or a standard control oligonucleotide
(MO-control), diluted in 0.2 mol/liter KCl, were microin-
jected into one-cell-stage zebrafish embryos [20]. For
rescue experiments 0.32 ng of pDestTol2CG2-shox2 or
pDestTol2CG2-isl1 was microinjected into one-cell-stage
embryos directly after injection of 2.8 ng of shox2-MO.
For histology, embryos were fixed in 4 % paraformal-
dehyde and embedded in JB-4 (Polysciences, Inc). Then,
5-lm sections were cut, dried, and stained with hematox-
ylin and eosin [43].
For immunoblotting, monoclonal mouse IgG1 anti-rat
islet1 antibody (Developmental Studies Hybridoma Bank,
DSHB, University of Iowa) and polyclonal anti pan-cad-
herin (Abcam) were used. Proteins were separated by SDS-
PAGE and transferred to polyvinylidene fluoride (PVDF)
membrane. Blots were probed with the mentioned anti-
bodies, signals were detected by chemiluminescence
(monoclonal anti-rabbit-Hrp and anti-mouse-Hrp) and
imaging was performed with Image Quant LAS4000mini
(GE Healthcare). Quantification of the immunoblot was
performed using the Image Quant TL software.
Whole-mount antisense RNA in situ hybridization was
carried out as described [21] using a digoxigenin-labeled
antisense probe for zebrafish shox2 and islet1. For immu-
nostaining, zebrafish embryos were fixed in Dent’s fixative
and a monoclonal anti-acetylated tubulin antibody (Sigma)
was used [40].
Statistical analysis
Data are presented as mean ± SEM from at least three
independent experiments. Comparisons between experi-
mental groups were performed using paired t test or 1-way
ANOVA. Differences were considered significant if they
showed a value of P \ 0.05.
Results
Shox2 has regulatory effects on Isl1 expression
in the developing sinoatrial node
To identify novel transcriptional targets of Shox2, we
performed microarray analysis and compared gene
expression levels in right atria of wildtype and Shox2-/-
hearts. Only right atria comprising the Shox2 expressing
sinus venosus myocardium and venous valves were dis-
sected from murine E11.5 hearts to increase the specificity
of the array analysis. Genes were considered to be up- or
downregulated if they showed log2 ratios of C0.35 or
B-0.4 with a significance of P B 0.0001. Using these
selection criteria, we identified 321 genes with significantly
altered gene expression (80 up- and 241 downregulated
genes). As expected, Shox2 was among the highest nega-
tively regulated genes. Classification of the 321 genes into
gene families using the Gene Set Enrichment Analysis
(GSEA) revealed that the highest proportion of regulated
genes belongs to the group of transcription factors. Among
these, the LIM homeodomain transcription factor Isl1
showed a reduced expression in right atria of Shox2-/-
embryos.
To verify Isl1 as a putative target gene, we carried out
qRT-PCR analyses using right atrial tissue samples of
wildtype and Shox2 knockout embryos and confirmed the
downregulation of Isl1 expression in a second independent
pool of embryonic heart tissue (Fig. 1A). To further
investigate Isl1 as a putative target gene of Shox2, we
compared the spatial expression of both genes and found
that Shox2 and Isl1 expression overlap in embryonic mouse
hearts. Isl1 expression was detected in the SAN of wildtype
hearts, which corresponds to the area where Shox2 nor-
mally is expressed (Fig. 1B). Whole-mount in situ
hybridization on isolated E11.5 wildtype and knockout
hearts demonstrated that Isl1 transcripts are completely
absent in the SAN region of Shox2 mutants (Fig. 1C b’),
while normal expression was observed in the outflow tract
(Fig. 1C b). The lack of Isl1 expression in the SAN, but
unaffected Isl1 expression in the outflow tract of Shox2-
null mice could be also confirmed at embryonic stage
E12.5 (Fig. S1A). In situ analyses revealed a complete loss
of Isl1 expression in the right atrium (SAN) of knockout
hearts, suggesting that the residual Isl1 expression detected
in Shox2 knockout tissue by qRT-PCR and microarray
experiments is likely due to some remaining outflow tract
tissue following microdissection. Quantitative expression
analysis using outflow tract tissue samples showed high
and consistent Isl1 expression levels in both wildtype and
Shox2 knockout embryos (Fig. S1B).
To validate that the loss of Isl1 expression in the SAN of
Shox2 knockout hearts is not due to incorrect formation of
SAN tissue, we examined the expression of SAN markers
in wildtype and knockout hearts using in situ hybridization
and immunohistochemistry. While Tbx18 is mainly
expressed in the SAN head, Hcn4 is a very prominent
marker of the complete developing SAN [45, 56]. Double
in situ hybridization experiments using an Isl1 antisense
probe together with Hcn4 showed coexpression in the SAN
of E12.5 and E13.5 wildtype hearts (Fig. 2A a, a’, c, c’). In
Shox2-/- mouse hearts Isl1 expression is completely
absent in this region, while Hcn4 transcripts are still
detectable (Fig. 2A b, b’, d, d’). Double immunostainings
revealed that Hcn4 and Tbx18 colocalize with Isl1 in the
SAN of E11.5 wildtype embryos (Fig. 2B a, g). While both
markers could be detected in the SAN of wildtype and
knockout hearts (Fig. 2B c, f, i, l), Isl1 staining is not
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detectable in this region in Shox2-/- embryos (Fig. 2B e,
k). Together, these stainings confirm the loss of Isl1
expression in the SAN of Shox2 mutants on transcript and
protein level at different embryonic stages, while the
presence of Hcn4 and Tbx18 confirm that the SAN is
formed. The loss of Isl1 expression is thereby very likely
linked to Shox2 deficiency and does not constitute an
indirect effect due to disrupted development of SAN tissue
in knockout embryos.
SHOX2 binds to regulatory elements in an intronic
region of the ISL1 gene
To further study the transcriptional control mechanism of
ISL1 by SHOX2, we investigated specific binding sites
within the ISL1 locus. As a first step, we performed mul-
tispecies conservation analysis for the human ISL1 locus to
identify evolutionary conserved regions. Conservation
of DNA sequences provides a route for identifying func-
tional elements in genomes [32]. Sequence comparison of
human, frog, chicken, and mouse Isl1 revealed several
highly conserved regions (Fig. S2A). Using luciferase
assays, we functionally characterized these highly con-
served elements. The reporter constructs used are depicted
as black boxes below the conservation plot in Supple-
mental Material Fig. S2A and are referred to as ISL1-
reporter-1 to ISL1-reporter-5. ISL1-reporter-3 and -4
include regulatory elements previously identified down-
stream of the translational stop codon [22, 23], while ISL1-
reporter-1 contains a recently published minimal promoter
of the Isl1 gene [31]. Cotransfections of the different ISL1
reporter constructs along with a SHOX2a expression plas-
mid revealed a strong increase in luciferase activity only
for ISL1-reporter-2, compared to the basal level of the
respective reporter alone (Fig. S2B). By transfection of
serial gene deletion constructs (genomic locations of the
constructs are depicted in Fig. 3A), we confined the
SHOX2 transcriptional regulatory element to a 184-bp
region located in the second intron of ISL1, corresponding
to ISL1-reporter-2del 3 (Fig. 3A, B). To identify the pre-
cise SHOX2 binding site, EMSA was performed using four
different oligonucleotide probes (Oligo1–Oligo4; Fig.
S3A) that cover the respective intronic ISL1 sequence. We
obtained a shift with both Oligo1 (strong binding) and 3
(weaker binding), but not with Oligo2 and 4 (Fig. 3C,
Fig. S3B). Competitive EMSAs demonstrated that only
high excess (150-fold) of unlabeled Oligo3 (SpC3) com-
petitively affects binding of Oligo1 to SHOX2 (Fig. S4A,
left panel), while already a low molar excess (50-fold) of
unlabeled Oligo1 (SpC1) competitively inhibits binding of
labeled Oligo3 to SHOX2 (Fig. S4A, right panel). Our
luciferase assays also show that the sequence encompass-
ing Oligo1 alone is not sufficient to activate ISL1 by
SHOX2 (as this region was also partly included in the
ISL1-reporter-2del 2 construct which did not show an
increase in luciferase activity upon cotransfection with
SHOX2) (Fig. 3B), suggesting that both sequences
(encompassing Oligo1 and Oligo3) are necessary to acti-
vate the ISL1 gene by SHOX2. Oligo1 and Oligo3
both include AATT-palindromic sequences, which were
Fig. 1 Shox2 deficiency impairs Isl1 expression. A qRT-PCR
analysis using right atrial tissue of E11.5 wildtype and Shox2-/-
mouse hearts. Shox2 knockout results in 34 % reduction of Isl1
mRNA levels in the right atrium of the heart. All results were
normalized to Sdha (succinate dehydrogenase complex, subunit A)
and Hprt1 (hypoxanthine phosphoribosyltransferase 1) mRNA values.
(** P = 0.0058; n = 21 right atria from 6 different pregnancies and
6 independent experiments). B Coexpression of Shox2 and Isl1 in the
embryonic mouse heart. Sections after whole-mount in situ hybrid-
ization on E11.5 wildtype mouse hearts using Shox2 (upper section)
and Isl1 (lower section) RNA probes. Murine Shox2 and Isl1 are
coexpressed specifically in the SAN region of the developing heart
(indicated by black arrowheads). C Isl1 expression is absent in the
SAN of Shox2-/- embryos. Whole-mount in situ hybridization on
E11.5 wildtype (a) and Shox2-/- (b) mouse hearts using an Isl1 RNA
probe. Both, ventral (a, b) and dorsal (a’, b’) views are shown.
Murine Isl1 is expressed in the OFT (a) and in the SAN (a’) of the
developing heart in wildtype embryos. In the Shox2-/- mouse heart,
Isl1 expression is still present in the OFT (b) but completely absent in
the SAN (b’), where Shox2 and Isl1 expression domains overlap in
the wildtype heart. RA right atrium, LA left atrium, RV right ventricle,
LV left ventricle, OFT outflow tract, SAN sinoatrial node
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mutated to CCGG (Oligo1 mut and Oligo3 mut) to confirm
sequence specific binding. No shift was obtained using the
mutated Oligos, confirming that the AATT motif is
essential for SHOX2 binding (Fig. 3C). In addition,
competition assays revealed that an excess of unlabeled
wildtype Oligos (SpC1 and SpC3) reduce the DNA binding
ability of SHOX2, whereas excess of mutant Oligos (MuC1
and MuC3) do not affect the binding (Fig. S4B).
Fig. 2 Double staining of
wildtype and Shox2-/-
embryos. A Double whole-
mount in situ hybridization with
corresponding sections (50 lm)
on E12.5 (a, b) and E13.5
(c, d) wildtype and Shox2-/-
mouse hearts using Isl1 and
Hcn4 RNA probes. Murine Isl1
(blue staining) and Hcn4 (red
staining) are expressed in the
SAN (a, a’, c, c’) of the
developing heart in wildtype
embryos (indicated by black
arrowhead). In the Shox2-/-
mouse heart Isl1 expression is
completely absent in the SAN
(b, b’, d, d’), which represents
the overlapping expression
domains of Shox2 and Isl1 in the
wildtype heart. Note that Hcn4,
another marker of the SAN
region, is still expressed in
Shox2-/- hearts, even if the
expression is somewhat reduced
(b, b’, d, d’). B Transverse
sections (10 lm) of E11.5
wildtype (a–c; g–i) and
Shox2-/- (d–f; j–l) embryos
were stained with Isl1 (red) and
the SAN marker Hcn4 or Tbx18
(green). Nuclei are
counterstained with Hoechst
(blue). Isl1 and Hcn4 expression
clearly overlaps in the SAN
region of wildtype embryos
(a; white arrowhead). Hcn4 is
still detectable in the SAN of
Shox2-/- embryos (f), whereas
no Isl1 staining is visible in this
region (e). Isl1 and Tbx18
expression clearly overlaps in
the SAN head of wildtype
embryos (g; white arrowhead).
Tbx18 is still detectable in the
SAN of Shox2-/- embryos (l),
whereas no Isl1 staining is
visible in this region (k). RA
right atrium, LA left atrium, RV
right ventricle, LV left ventricle,
SAN sinoatrial node. Scale bars:
a–f 1,000 lm; g–l 500 lm
Page 6 of 11 Basic Res Cardiol (2013) 108:339
123
Bradycardia caused by shox2 deficiency depends
on isl1 expression
To functionally assess whether Shox2 and Isl1 act in the
same genetic pathway, we injected zebrafish embryos with
morpholinos (MO). When injecting either 2.8 ng of shox2-
MO or isl1-MO, 82.0 ± 2.6 % (n = 175; 2 independent
experiments) and 79.1 ± 0.3 % (n = 182; 2 independent
experiments) of injected embryos, respectively, displayed
pericardial edema (Fig. 4A asterisk) and a severely reduced
heart rate (Fig. 4B). Embryonic heart morphogenesis pro-
ceeds normally in shox2-MO and isl1-MO injected zebra-
fish. By 72-h post fertilization (hpf), morphant hearts
consist of two heart chambers, atrium and ventricle, with
properly developed myocardial and endocardial cell layers.
The similarity of phenotypes between shox2 and isl1
deficiency in the fish raised the possibility that a close
functional interaction between these two genes exists. To
address whether the observed cardiac dysfunction caused
by shox2 deficiency could depend on isl1 function, we
examined the ability of isl1 to compensate the morpholino-
mediated loss of shox2 function by transient rescue
experiments. DNA constructs expressing isl1 and shox2
under the control of the cardiac myosin light chain 2
(cmlc2) promoter [18, 33], which drives myocardial-spe-
cific expression were used for the rescue experiment. The
cmlc2 promoter also drove expression of GFP, which
allowed monitoring of cardiomyocyte-specific expression
(Fig. S5A). We coinjected 0.32 ng of the isl1-expression
construct along with 2.8 ng shox2-MO, which was suffi-
cient to induce the bradycardia phenotype and subse-
quently measured the heart rate of GFP positive embryos
after 72 hpf. Myocardial-specific expression of isl1 could
significantly rescue the reduced heart rate in shox2 mor-
phant embryos. As a control, injection of the isl1- or shox2-
expression construct alone did not cause any changes in
embryonic heart rate (Fig. 4C). Histological sections of
shox2-MO injected hearts rescued by isl1 overexpression
show normal development of the heart without formation
of pericardial edema (Fig. 4D), compared to those of
shox2-MO injected embryos alone (Fig. 4A). In addition,
we could show a downregulation of isl1 protein levels in
embryos injected with shox2-MO (Fig. S5B). Both pro-
teins, shox2 and isl1, are highly expressed during neural
development and isl1 plays an important role during dif-
ferentiation of neurons in the brain. To exclude that shox2
deficiency also affects differentiation of isl1 positive neu-
rons, we analyzed the isl1 expression after shox2 knock-
down by whole-mount in situ hybridization. Isl1 expression
in the brains of shox2 morphants is indistinguishable from
wildtype embryos (Fig. S6A and B). On the other hand, isl1
deficient embryos show a normal expression of shox2
in the head region (Fig. S6C and D). Furthermore, we
performed immunostaining using acetylated Tubulin as
Fig. 3 SHOX2 binds to regulatory elements within the ISL1 gene.
A Schematic drawing showing the position of the luciferase reporter
construct sequences within the genomic region of ISL1 and the probes
generated for EMSA. Boxes and lines represent exons and introns,
respectively. EMSA probes to which SHOX2 binds are indicated in
red. B SHOX2 increases the transcriptional activity of the ISL1-
reporter-2, as evaluated by luciferase assay. The responsive reporter
element was further narrowed down using deletion (del) constructs.
HEK 293 cells were transiently cotransfected with the indicated ISL1
reporter constructs or the empty pGL3 basic vector together with a
SHOX2 expression plasmid or an empty vector (pST-Blue1) and 24 h
after transfection, luciferase activity was determined. Experiments
were repeated at least three times in triplicate with consistent results
and representative data are shown. C EMSA revealed specific binding
using Oligo1 and Oligo3 together with a GST-SHOX2 fusion protein
(shifted band is marked by an arrowhead). Precise binding sites were
identified by the use of mutated probes (Oligo1 mut and Oligo3 mut),
with 4 nucleotides exchanged (AATT $ CCGG). Free oligo is
indicated by an arrow. Representative data from three independent
experiments with consistent results are shown
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neuronal marker (Fig. S6E and F). While the heart rate was
reduced after shox2-MO injection, no alteration could be
detected in neural development. Together, these results
indicate an epistatic relationship and a direct functional
link between shox2 and isl1 in the pacemaking system of
zebrafish embryos.
Discussion
During embryogenesis, the proper development of the
cardiac pacemaker is essential for a coordinated heart beat.
Defects in the transcriptional network controlling SAN
development may cause dysfunction of the primary pace-
maker resulting in severe arrhythmias. The elucidation of
the molecular mechanisms and key regulators involved in
these developmental processes is therefore crucial for our
understanding of arrhythmia-related diseases.
The LIM homeodomain transcription factor Isl1 is a
prominent marker of second heart field derivatives com-
prising the right ventricle, outflow tract, inflow tract with
the SAN and parts of the atria and plays a crucial role in
cardiogenesis [6, 49, 51]. SAN development is initiated in
the presence of Isl1 expressing second heart field-derived
cells [35, 48, 51]. Homozygous loss of Isl1 results in
embryonic lethality between E10.5 and E11.0 due to severe
cardiac abnormalities. Besides heart looping defects,
Isl1-/- embryos show hypoplasia or complete absence of
the right ventricle, the outflow tract and parts of the atria
including the inflow tract [6]. Early in embryogenesis, Isl1
positive cells, which exhibit multipotent properties [4, 36],
contribute to both the arterial (outflow tract) and the venous
Fig. 4 shox2-MO-mediated bradycardia can be rescued by isl1
overexpression. A Injection of 2.8 ng shox2 and isl1 antisense
morpholinos (shox2-MO and isl1-MO) leads to pericardial edema and
pericardial blood congestion due to reduced heart rates in zebrafish
embryos. Lateral views of WT, shox2-MO and isl1-MO injected
embryos 72 h post fertilization (hpf). Hematoxylin and eosin staining
of sagittal histological sections of WT (left), shox2-MO (middle) and
isl1-MO (right) morphant hearts 72 hpf. Endocardial and myocardial
layers of ventricle and atrium are defined, and heart chambers are
separated by an atrioventricular ring. B Heart rates of shox2 and isl1
morphants are decreased by 72 hpf. Injection of shox2-MO leads to
sinus bradycardia with heart frequencies of 130 beats per min (bpm)
compared to WT embryos with 172 bpm. isl1 deficient embryos
exhibit severe sinus bradycardia and frequent pauses in the cardiac
contraction with heart frequencies of 59 bmp. (***P \ 0.001).
C shox2-MO-mediated bradycardia is partially rescued by
cardiomyocyte-specific expression of isl1. The mean heart rate of
WT embryos 72 hpf amounts to 160 bpm. After shox2 knockdown
(2.8 ng shox2-MO) the heart rate is reduced to 114 bpm. Cardiomy-
ocyte-specific overexpression of shox2 or isl1 alone (0.32 ng) does
not affect the heart beat. Coinjection of 0.32 ng shox2 or isl1 plasmid
DNA along with 2.8 ng shox2-MO results in significantly increased
heart frequencies (134 and 137 bmp) compared to shox2-MO-injected
embryos (114 bpm) at 72 hpf (****P \ 0.001; n = 32–40 per
condition). D Hematoxylin and eosin staining of sagittal histological
heart sections of WT (left) and shox2-MO embryos rescued by isl1
overexpression (right) 72 hpf revealed that the rescued hearts,
compared to those of shox2-MO injected embryos (A, middle
picture), show a phenotype very similar to the WT (left). WT
wildtype, asterisk pericardial edema, double asterisks no pericardial
edema
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pole (SAN) of the primary heart tube. Once these pro-
genitor cells differentiate into cardiomyocytes, Isl1 expres-
sion becomes downregulated and almost extinguished from
E12.5 to E18.5 [27]. Small numbers of Isl1 positive cells can
still be detected in the adult hearts, including the SAN [14, 24,
54].
Although signaling pathways up- and downstream of
Isl1 have been investigated in the past [1, 6, 8, 26, 39], little
is known about direct regulators controlling the transcrip-
tional activity of this gene in cardiac cells. The only pro-
teins known to regulate Isl1 expression so far via direct
binding are ß-Catenin [28], Forkhead- and Gata4 tran-
scription factors [22, 23] and the POU homeodomain
transcription factor Oct1 [31]. While the binding sites for
these regulators reside in promoter and enhancer regions
up- or downstream of the gene, we could identify a regu-
latory element within an intronic region of ISL1.
In the present study, a connection between the homeo-
domain transcription factor Shox2 and Isl1 was revealed
during cardiac development. We could show that Shox2 is
essential for the expression of Isl1 in the SAN. Based on
luciferase reporter studies and EMSA, our data also dem-
onstrated that SHOX2 directly regulates ISL1 expression
and that this regulation is conducted via the binding to an
intronic regulatory element of ISL1. To study the tran-
scriptional regulation of isl1 by shox2 in vivo, zebrafish
was employed as a model. We have shown previously that
shox2 loss of function in zebrafish embryos results in
severe cardiac dysfunction with sinus bradycardia and
intermittent sinus exit block after 72 h of development [2].
Similar data have also been published for Isl1 [9] and we
could confirm these findings experimentally. Furthermore,
it has been shown that both genes are expressed at the
venous pole of the atrium in zebrafish embryos (48–72 hpf)
[2, 57]. In the present study, we demonstrate a functional
link between shox2 and isl1 in zebrafish embryos by par-
tially rescuing the shox2-mediated bradycardia via ectopic
expression of isl1. Previously, two separate phases of
cardiomyocyte differentiation have been shown to exist in
zebrafish. The first process, which regulates the differen-
tiation of the venous pole comprising the sinus venosus
requires Isl1 expression, while in a second Fgf8-dependent
process new cells are added to the arterial pole of the heart
[9]. Interestingly, in both Isl1 mutant fish and Shox2
knockout mice, Bmp4 expression is lost in the inflow tract
(sinus venosus), but not the outflow tract of the developing
heart [9, 42]. In addition, deficiency of both Isl1 and Shox2
in fish, as well as Shox2 deficiency in the mouse results in a
bradycardia phenotype [2, 9]. The similarity of the phe-
notypes observed in Isl1 and Shox2 mutants point to a
genetic link between these two genes in the development or
function of the cardiac pacemaker. Taken together, our
findings revealed an interesting interplay between Shox2
and Isl1 in the SAN, which contributes to a novel tran-
scriptional regulation in the cardiac pacemaker system
(Fig. 5).
Based on the established functional data, SHOX2 as
well as SHOX2 targets represent excellent candidates for
human arrhythmias. While genetic variation in ISL1 is
associated with congenital heart disease and cardiomyop-
athies [13, 47], SHOX2 has not been linked to any human
phenotype yet. In a SHOX/Shox2 replacement mouse
model, it was recently shown that a hypomorphic SHOX
allele is not able to completely rescue the Shox2-/- cardiac
phenotype. Although the mice survive, they still show
arrhythmias, suggesting that SHOX2 haploinsufficiency
may lead to arrhythmia in humans [29]. Thus, it will be
interesting to see if both SHOX2 and ISL1 are involved in
human heart disease, especially arrhythmias.
A possible connection between Isl1 expressing second
heart field-derived cells and the formation of the cardiac
conduction system has been previously proposed [35, 48,
54]. As Shox2 directly regulates Isl1 expression specifi-
cally in the embryonic SAN, our data show for the first
time a direct functional consequence for Isl1 in the pace-
making system of the developing heart. Taken together, our
data add another piece to the puzzle of regulatory tran-
scriptional networks controlling the development of the
pacemaker.
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